Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2013 | A 12-year ecological study of hip fracture rates among older Taiwanese adults | DING-CHENG CHAN ; Lee Y.-S.; Wu Y.-J.; Tsou H.-H.; Chen C.-T.; Hwang J.-S.; KEH-SUNG TSAI ; RONG-SEN YANG | Calcified Tissue International | 28 | 27 | |
2011 | ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment | Lin K.-M.; Chiu Y.-F.; Tsai I.J.; Chen C.-H.; Shen W.W.; Liu S.C.; SHAO-CHUN LU ; Liu C.-Y.; Hsiao M.-C.; Tang H.-S.; Liu S.-I.; Chang L.-H.; CHI-SHIN WU ; Tsou H.-H.; Tsai M.-H.; Chen C.-Y.; Wang S.-M.; Kuo H.-W.; Hsu Y.-T.; Liu Y.-L. | Pharmacogenetics and Genomics | 69 | 77 | |
2014 | Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study | CHIUN HSU ; Tsou H.-H.; Lin S.-J.; Wang M.-C.; MING YAO ; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; HWEI-FANG TIEN ; Liu T.-W.; PEI-JER CHEN ; ANN-LII CHENG | Hepatology | 215 | 198 | |
2022 | A comprehensive evaluation of COVID-19 policies and outcomes in 50 countries and territories | Tsou H.-H.; Kuo S.-C.; Lin Y.-H.; Hsiung C.A.; Chiou H.-Y.; WEI J. CHEN ; Wu S.-I.; Sytwu H.-K.; PAU-CHUNG CHEN ; Wu M.-H.; Hsu Y.-T.; Wu H.-Y.; Lee F.-J.; Shih S.-M.; Liu D.-P.; SHAN-CHWEN CHANG | Scientific Reports | 5 | 5 | |
2020 | Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection | Tsou H.-H.; HUNG-CHIH YANG ; Hsiao C.-F; Hsiung C.A; Liu T.-W; Chuang M.-H; Wu H.-Y; Hsu Y.-T; Tsui C.-W; PEI-JER CHEN ; ANN-LII CHENG ; CHIUN HSU ; Taiwan Cooperative Oncology Group | Journal of the Formosan Medical Association | 8 | 6 | |
2013 | CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions | Kuo H.-W.; Liu S.C.; Tsou H.-H.; Liu S.-W.; Lin K.-M.; SHAO-CHUN LU ; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Chen C.-H.; Lu M.-L.; Shen W.W.; Tang H.-S.; Liu S.-I.; Chang L.-H.; Wu H.-Y.; Chang Y.-S.; Yeh T.-K.; Chen A.C.; Liu Y.-L. | Pharmacogenomics | 20 | 15 | |
2010 | CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine | Lin K.-M.; Tsou H.-H.; Tsai I.-J.; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Shen W.W.; Tang H.-S.; Fang C.-K.; CHI-SHIN WU ; SHAO-CHUN LU ; Kuo H.-W.; Liu S.C.; Chan H.-W.; Hsu Y.-T.; Tian J.-N.; Liu Y.-L. | Pharmacogenomics | 34 | 30 | |
2011 | CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer | Wang S.-C.; Ho I.-K.; Tsou H.-H.; Tian J.-N.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU ; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Lin K.-M.; Chen C.-Y.; Liu S.C.; Wu H.-Y.; Chan H.-W.; Tsai M.-H.; Lin P.-S.; Liu Y.-L. | Journal of Clinical Psychopharmacology | 68 | 59 | |
2016 | Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer | Chiang N.-J.; CHIUN HSU ; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Huang S.-F.; Chen L.-T. | Scientific Reports | 16 | 14 | |
2013 | Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort | Wang S.-C.; Ho I.-K.; Tsou H.-H.; Liu S.-W.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU ; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Lin K.-M.; Liu S.C.; Wu H.-Y.; Kuo H.-W.; Chen A.C.H.; Chang Y.-S.; Liu Y.-L. | OMICS A Journal of Integrative Biology | 37 | 32 | |
2017 | Integrated care for geriatric frailty and sarcopenia: a randomized control trial | DING-CHENG CHAN ; Tsou H.-H.; CHIRN-BIN CHANG ; RONG-SEN YANG ; JAU-YIH TSAUO ; Chen C.-Y.; Hsiao C.-F.; Hsu Y.-T.; Chen C.-H.; Chang S.-F.; Hsiung C.A.; Kuo K.N. | Journal of Cachexia, Sarcopenia and Muscle | 44 | 44 | |
2020 | Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study | Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG ; CHIUN HSU ; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. | Liver International | 5 | 5 | |
2021 | Nonpolio enterovirus activity during the COVID-19 Pandemic, Taiwan, 2020 | Kuo S.-C.; Tsou H.-H.; Wu H.-Y.; Hsu Y.-T.; Lee F.-J.; Shih S.-M.; Hsiung C.A.; WEI J. CHEN | Emerging Infectious Diseases | 9 | 9 | |
2012 | A pilot randomized controlled trial to improve geriatric frailty | DING-CHENG CHAN ; Tsou H.-H.; RONG-SEN YANG ; JAU-YIH TSAUO ; Chen C.-Y.; Hsiung C.A.; Kuo K.N. | BMC Geriatrics | 101 | 95 | |
2012 | UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients | Tian J.-N.; Ho I.-K.; Tsou H.-H.; Fang C.-P.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU ; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Chen Y.-T.; Liu S.C.; Hsu Y.-T.; Kuo H.-W.; Liu C.T.; Yang Y.-T.; Chen A.C.H.; Shih Y.-H.; Liu Y.-L. | Pharmacogenomics | 29 | 24 |